1. Tips on using my ppt.
1. You can freely download, edit, modify and put your
name etc.
2. Don’t be concerned about number of slides. Half the
slides are blanks except for the title.
3. First show the blank slides (eg. Aetiology ) > Ask
students what they already know about ethology of
today's topic. > Then show next slide which enumerates
aetiologies.
4. At the end rerun the show – show blank> ask questions >
show next slide.
5. This will be an ACTIVE LEARNING SESSION x
three revisions.
6. Good for self study also.
7. See notes for bibliography.
3. Inflammatory bowel disease (IBD)
• Inflammatory bowel disease (IBD) is an idiopathic
disease caused by a dysregulated immune
response to host intestinal microflora.
• The two major types of inflammatory bowel
disease are ulcerative colitis (UC), which is
limited to the colonic mucosa, and Crohn disease
(CD), which can affect any segment of the
gastrointestinal tract from the mouth to the anus,
involves "skip lesions," and is transmural.
• There is a genetic predisposition for IBD, and
patients with this condition are more prone to the
development of malignancy.
6. Introduction & History.
• Ulcerative colitis (UC) is idiopatic
inflammatory disease potentially affecting
the entire large bowel (colon and rectum).
• The inflammation is confined to mucosa.
• UC can go into remission and recur.
• Extraintestinal manifestations.
9. Aetiology
• Certain types of food composition
• Oral contraceptives
• Protective effect of tobacco seen in
ulcerative colitis
• Disturbed intestinal flora.
15. Microscopic Pathology
• Acute and chronic inflammatory infiltrate of
the lamina propria, crypt branching, and
villous atrophy are present in ulcerative
colitis.
• Inflammation of the crypts of lieberkühn
and abscesses.
• Granulomas are also seen in tuberculosis,
yersiniosis, and can even be seen in
ulcerative colitis
16. Microscopic Pathology
• The ulcerated areas are soon covered by
granulation tissue
• Inflammatory polyps or pseudopolyps.
• Excessive fibrosis is not a feature of the
disease
18. Grading
• Mild: Bleeding per rectum, fewer than four
bowel motions per day
• Moderate: Bleeding per rectum, more than
four bowel motions per day
• Severe: Bleeding per rectum, more than
four bowel motions per day, and a systemic
illness with hypoalbuminemia (< 30 g/L)
22. Demography
• The annual incidence is 10.4-12 cases per
100,000 people, and the prevalence rate is
35-100 cases per 100,000 people.
• Three times more common than Crohn
disease
• White individuals living in Western
industrialized nations
• 2-4 times higher in Ashkenazi Jews.
23. Demography
• Bimodal pattern, with a peak at 15-25 years
and a smaller one at 55-65 years, although
the disease can occur in people of any age.
• Slightly more common in women than in
men.
24. Demography:Geographical
distribution
• Ulcerative colitis is more common in the
Western and Northern hemispheres; the
incidence is low in Asia and the Far East.
• As new regions assume Western cultural
practices, an increased prevalence of
ulcerative colitis is usually found
approximately 1 decade before the observed
increase in Crohn disease.
26. Symptoms
• Rectal bleeding
• Frequent stools
• Mucous discharge from the rectum
• Tenesmus (occasionally)
• Lower abdominal pain and severe
dehydration from purulent rectal discharge
(in severe cases, especially in the elderly).
27. Symptoms
In some cases, UC has a fulminant course
marked by the following:
• Severe diarrhea and cramps
• Fever
• Leukocytosis
• Abdominal distention
28. Symptoms
• Colonic Crohn disease may be clinically
indistinguishable from ulcerative colitis,
with symptoms of bloody mucopurulent
diarrhea, cramping abdominal pain, and
urgency to defecate.
31. Signs
• Normal in mild disease
• Mild tenderness in the lower left abdominal
quadrant
Severe cases-
• Fever
• Tachycardia
• Significant abdominal tenderness
• Weight loss
33. Prognosis: IBD
• Both are lifelong diseases.
• For both conditions, the overall mortality
has decreased steadily, and currently is less
than 5%.
• Both follow a more severe course in
children and adolescents
• Both are at increased risk for the later
development of cancer.
• The excess risk is limited to colorectal
cancer
34. Prognosis
• Most patients with these diseases are able to
maintain normal occupations and enjoy
reasonably stable social and economic
situations.
• Ulcerative colitis is curable with
proctocolectomy and ileostomy.
43. Imaging Studies
1. Endoscopy and biopsy-Abnormal
erythematous mucosa, with or without
ulceration, extending from the rectum to a
part or all of the colon
2. Uniform inflammation, without intervening
areas of normal mucosa (skip lesions tend
to characterize Crohn disease)
3. Contact bleeding may also be observed,
with mucus identified in the lumen of the
bowel
48. Radiography
• Pseudopolyposis
• Deep ulcers
• The colon may appear shortened
• Loss of colonic haustra
• Toxic megacolon -massive colonic dilatation
associated with an abnormal mucosal contour.
• Colonic perforation
• Thumbprinting
• Long stricture/spasm of the ascending
colon/cecum
• Increased postrectal space
58. Non Operative Therapy
• Mild disease confined to the rectum: Topical
mesalazine via suppository (preferred) or
budesonide rectal foam
• Left-side colonic disease: Mesalazine suppository
and oral aminosalicylate (oral mesalazine is
preferred to oral sulfasalazine)
• Systemic steroids, when disease does not quickly
respond to aminosalicylates
• Oral budesonide
• After remission, long-term maintenance therapy
(eg, once-daily mesalazine)
59. Non Operative Therapy
• Medical treatment of acute, severe UC
• Hospitalization
• Intravenous high-dose corticosteroids
• Alternative induction medications:
Cyclosporine, Tofacitinib
• tacrolimus, infliximab, adalimumab,
golimumab
61. Operative Therapy
• Indications for urgent surgery include the
following:
1. Toxic megacolon refractory to medical
management
2. Fulminant attack refractory to medical
management
3. Uncontrolled colonic bleeding
62. Operative Therapy
• Indications for elective surgery -
1. Long-term steroid dependence
2. Dysplasia or adenocarcinoma found on
screening biopsy
3. Disease being present for 7-10 years
63. Operative Therapy
Surgical options -
• Total colectomy (panproctocolectomy) and
ileostomy
• Total colectomy Ileoanal pouch
reconstruction or ileorectal anastomosis
• In an emergency, subtotal colectomy with
end-ileostomy
64. Operative Therapy
• UC is generally limited to the colon, apart
from minimal distal "back-wash" ileitis;
• ulcerative colitis usually involves only the
mucosal layer of the bowel, and, in some
cases, superficial submucosa, unless there is
fulminant colitis
• may also manifest cecal or appendiceal
patches of involvement that can simulate
the "skip" lesions of CD
•
68. Take Home Messages
• UC is generally limited to the colon, apart
from minimal distal "back-wash" ileitis;
• ulcerative colitis usually involves only the
mucosal layer of the bowel, and, in some
cases, superficial submucosa, unless there is
fulminant colitis
• may also manifest cecal or appendiceal
patches of involvement that can simulate
the "skip" lesions of CD
•
69. Take Home Messages
• risk of neoplastic transformation, the risk
is higher
• continuous process, worse distally, with
increased span of involvement distal to
proximal, as the disease progresses
• Surgical intervention is better tolerated in
UC
70. Get this ppt in mobile
1. Download Microsoft
PowerPoint from play
store.
2. Open Google assistant
3. Open Google lens.
4. Scan qr code from
next slide.
71.
72. Get this ppt in mobile
1. Download Microsoft
PowerPoint from play
store.
2. Open Google assistant
3. Open Google lens.
4. Scan qr code from
next slide.